Thomas Francis

7.3k total citations · 1 hit paper
54 papers, 1.7k citations indexed

About

Thomas Francis is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Infectious Diseases. According to data from OpenAlex, Thomas Francis has authored 54 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 12 papers in Cardiology and Cardiovascular Medicine and 10 papers in Infectious Diseases. Recurrent topics in Thomas Francis's work include Influenza Virus Research Studies (24 papers), Respiratory viral infections research (12 papers) and Viral Infections and Immunology Research (10 papers). Thomas Francis is often cited by papers focused on Influenza Virus Research Studies (24 papers), Respiratory viral infections research (12 papers) and Viral Infections and Immunology Research (10 papers). Thomas Francis collaborates with scholars based in United States, United Kingdom and Malaysia. Thomas Francis's co-authors include Fred M. Davenport, Albert V. Hennessy, John A. Napier, Arnold S. Monto, Keith E. Jensen, Elva Minuse, Frederick H. Epstein, Norman S. Hayner, Marcus O. Kjelsberg and H. F. Maassab and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Thomas Francis

48 papers receiving 1.4k citations

Hit Papers

EPIDEMIOLOGIC AND IMMUNOLOGIC SIGNIFICANCE OF AGE DISTRIB... 1953 2026 1977 2001 1953 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Francis United States 21 1.1k 440 248 175 156 54 1.7k
G. C. Schild United Kingdom 24 1.0k 0.9× 347 0.8× 278 1.1× 214 1.2× 132 0.8× 64 1.5k
J. S. Oxford United Kingdom 18 1.0k 0.9× 262 0.6× 273 1.1× 195 1.1× 91 0.6× 43 1.2k
C. H. Stuart‐Harris United Kingdom 19 850 0.7× 273 0.6× 207 0.8× 121 0.7× 75 0.5× 75 1.4k
P. Chakraverty United Kingdom 18 958 0.8× 287 0.7× 174 0.7× 111 0.6× 38 0.2× 32 1.1k
Dorothy Hamre United States 17 616 0.5× 872 2.0× 109 0.4× 120 0.7× 92 0.6× 30 1.4k
M. Aymard France 22 822 0.7× 426 1.0× 189 0.8× 191 1.1× 128 0.8× 97 1.5k
Lidia B. Brydak Poland 22 1.3k 1.1× 486 1.1× 447 1.8× 117 0.7× 116 0.7× 157 1.8k
H. W. Doerr Germany 24 996 0.9× 577 1.3× 276 1.1× 296 1.7× 63 0.4× 67 1.8k
Lihan Yan United States 20 1.3k 1.1× 432 1.0× 450 1.8× 338 1.9× 85 0.5× 30 1.8k
DONALD L. EDDINS United States 15 554 0.5× 409 0.9× 129 0.5× 52 0.3× 26 0.2× 19 1.1k

Countries citing papers authored by Thomas Francis

Since Specialization
Citations

This map shows the geographic impact of Thomas Francis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Francis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Francis more than expected).

Fields of papers citing papers by Thomas Francis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Francis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Francis. The network helps show where Thomas Francis may publish in the future.

Co-authorship network of co-authors of Thomas Francis

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Francis. A scholar is included among the top collaborators of Thomas Francis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Francis. Thomas Francis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Francis, Thomas, et al.. (2025). Extracorporeal oxygenation for airway rescue: veno-venous ECMO in critical tracheal stenosis management: a single-centre case series. Indian Journal of Thoracic and Cardiovascular Surgery. 41(8). 1086–1091.
2.
Francis, Thomas, Eugenio Bringas, Inmaculada Ortíz, et al.. (2024). Environmental fluoxetine promotes skin cell proliferation and wound healing. Environmental Pollution. 362. 124952–124952.
3.
Francis, Thomas, et al.. (2023). Intramyocardial choristoma-a rare entity: first-ever case report and literature review. International Surgery Journal. 10(8). 1385–1387. 1 indexed citations
5.
Davenport, Fred M., Elva Minuse, Albert V. Hennessy, & Thomas Francis. (1969). Interpretations of influenza antibody patterns of man.. PubMed. 41(3). 453–60. 45 indexed citations
6.
Minuse, Elva, et al.. (1965). Studies of Antibodies to 1956 and 1963 Equine Influenza Viruses in Horses and Man. The Journal of Immunology. 94(4). 563–566. 37 indexed citations
7.
Davenport, Fred M., Albert V. Hennessy, J. Drescher, J. Mulder, & Thomas Francis. (1964). FURTHER OBSERVATIONS ON THE RELEVANCE OF SEROLOGIC RECAPITULATIONS OF HUMAN INFECTION WITH INFLUENZA VIRUSES. The Journal of Experimental Medicine. 120(6). 1087–1097. 26 indexed citations
8.
Neff, B. J., W. W. Ackermann, Frederick H. Epstein, & Thomas Francis. (1962). Inhibition of Vaccinial Hemagglutinins by Sera of Patients with Coronary Heart Disease and Other Chronic Illnesses. Circulation Research. 10(6). 836–845. 2 indexed citations
9.
Peterson, William, Fred M. Davenport, & Thomas Francis. (1961). A STUDY IN VITRO OF COMPONENTS IN THE TRANSMISSION CYCLE OF SWINE INFLUENZA VIRUS. The Journal of Experimental Medicine. 114(6). 1023–1033. 4 indexed citations
10.
Francis, Thomas. (1961). Aspects of the Tecumseh Study: Population Studies. Public Health Reports (1896-1970). 76(11). 963–963. 46 indexed citations
11.
Francis, Thomas. (1959). Influenza. Medical Clinics of North America. 43(5). 1309–1326. 4 indexed citations
12.
Jensen, Keith E., Elva Minuse, & Thomas Francis. (1957). Serologic Comparisons with Lines of Influenza Virus Isolated and Serially Transferred in Different Experimental Hosts. The Journal of Immunology. 78(5). 356–364. 7 indexed citations
13.
Jensen, Keith E., Fred M. Davenport, Albert V. Hennessy, & Thomas Francis. (1956). CHARACTERIZATION OF INFLUENZA ANTIBODIES BY SERUM ABSORPTION. The Journal of Experimental Medicine. 104(2). 199–209. 56 indexed citations
14.
Enders, John F., Joseph A. Bell, John H. Dingle, et al.. (1956). "Adenoviruses": Group Name Proposed for New Respiratory-Tract Viruses. Science. 124(3212). 119–120. 95 indexed citations
15.
Stuart‐Harris, C. H., et al.. (1955). EPIDEMIOLOGY OF INFLUENZA COMPARATIVE SEROLOGICAL OBSERVATIONS IN ENGLAND AND THE UNITED STATES. The Lancet. 266(6888). 469–474. 28 indexed citations
16.
Davenport, Fred M., et al.. (1953). EPIDEMIOLOGIC AND IMMUNOLOGIC SIGNIFICANCE OF AGE DISTRIBUTION OF ANTIBODY TO ANTIGENIC VARIANTS OF INFLUENZA VIRUS. The Journal of Experimental Medicine. 98(6). 641–656. 298 indexed citations breakdown →
17.
Jensen, Keith E. & Thomas Francis. (1953). Antigen-Antibody Precipitates in Solid Medium with Influenza Virus. The Journal of Immunology. 70(3). 321–325. 24 indexed citations
18.
Jensen, Keith E. & Thomas Francis. (1953). THE ANTIGENIC COMPOSITION OF INFLUENZA VIRUS MEASURED BY ANTIBODY-ABSORPTION. The Journal of Experimental Medicine. 98(6). 619–639. 53 indexed citations
19.
Davenport, Fred M. & Thomas Francis. (1951). A COMPARISON OF THE GROWTH CURVES OF ADAPTED AND UNADAPTED LINES OF INFLUENZA VIRUS. The Journal of Experimental Medicine. 93(2). 129–137. 23 indexed citations
20.
Francis, Thomas. (1951). Plan for the Evaluation of Vaccination Against Influenza. American Journal of Public Health and the Nations Health. 41(8_Pt_2). 62–68. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026